Reviewing the role of vascular endothelial growth factor in ovarian cancer and the feasibility and possible role of VEGF-targeted strategies in ovarian cancer treatment as well as their promises and challenges is the aim of this article. This evidence concerns the gene VEGFA and ovarian carcinoma.